Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Hair Contamination Leads to Hospira Aminosyn Recall September 4, 2013 Russell Maas Add Your Comments A recall has been issued for one lot of amino acid injection fluid manufactured by Hospira, after a consumer complaint was received involving at least one vial that was contaminated with hair.  The Aminosyn II recall was announced by the FDA on August 30, after a consumer found foreign matter in the solution, which Hospira later confirmed to be a human hair follicle. The affected lot of Aminosyn is an amino acid injection used at the user level to inject nitrogen and other vitamins for nutritional support for patients who are not capable of receiving oral nutrition is pill form. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Although no injuries have been reported in connection with the use of the amino acid injection fluid, injection of contaminated medications may cause a wide variety of problems depending upon a patient’s condition. According to the recall notice, patients typically may experience inflammation, phlebitis, and or low levels of allergic response but patients with more severe conditions with preexisting trauma may experience occluded capillaries and other high level risks. The recall includes Aminosyn II 10%, Sulfite-Free, 500mL flexible containers with NDC number 0409-4164-03, Lot number 26-138-JT and has an expiration date of August 1, 2014. The affected lot was manufactured by Hospira Inc. and distributed nationwide to wholesalers, distributors, hospitals, and pharmacies between March 2013 and August 2013. Hospira has been associated with multiple recalls over the past few years due to particulate matter contamination. Earlier this year, Hospira Inc. recalled one lot of .09% sodium chloride injection following a consumer complaint indicating particulates within the fluid which after further investigation were identified in four tested samples. Additionally, Hospira recalled 15 lots of Pipercillin and Tazobactam injection fluids as well as their GemStar Infusion System simultaneously due to particulate matter contamination and voltage defects in the infusion system. Those with existing product should verify the solution is part of the recalled lot and stop using/distributing the product immediately and quarantine it until they have called Stericycle at 1-866-737-4701 to arrange a return and replacement of the injection fluid. Tags: Drug Recall, Hospira, Particulate Matter Image Credit: | More Lawsuit Stories Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker March 19, 2025 AngioDynamics Lawsuit Claims Xcela Port Catheter Caused Acute Embolism March 19, 2025 Amazon Challenges Responsibility To Notify Customers About Recalled Products March 19, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (Posted: today) A federal judge has appointed the BioZorb lawyers to serve in various leadership positions during coordinated pretrial proceedings in the rapidly growing litigation, taking actions that benefit all plaintiffs pursuing a claim against Hologic. MORE ABOUT: BIOZORB LAWSUITBreast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025) Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (Posted: yesterday) A federal judge is expediting Depo-Provera brain tumor lawsuits towards resolution by permitting direct filing of new claims with the MDL court and appointing numerous plaintiffs’ attorneys to leadership roles. MORE ABOUT: DEPO-PROVERA LAWSUIT75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)Depo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025)Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (03/03/2025) Up to 100 Suboxone Tooth Decay Claims Can Be Filed on Single Lawsuit in MDL: Judge (Posted: 2 days ago) The U.S. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITSuboxone Lawyers Report on Status of Lawsuits Over Tooth Decay, Dental Damage (03/11/2025)Medical Records of Suboxone Tooth Decay Must Be Produced Under MDL Court Order (02/20/2025)Lawyers in Suboxone Dental Lawsuits Fail To Reach Agreement on Bellwether Selection Process (02/06/2025)
Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker March 19, 2025
Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (Posted: today) A federal judge has appointed the BioZorb lawyers to serve in various leadership positions during coordinated pretrial proceedings in the rapidly growing litigation, taking actions that benefit all plaintiffs pursuing a claim against Hologic. MORE ABOUT: BIOZORB LAWSUITBreast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)
Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (Posted: yesterday) A federal judge is expediting Depo-Provera brain tumor lawsuits towards resolution by permitting direct filing of new claims with the MDL court and appointing numerous plaintiffs’ attorneys to leadership roles. MORE ABOUT: DEPO-PROVERA LAWSUIT75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)Depo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025)Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (03/03/2025)
Up to 100 Suboxone Tooth Decay Claims Can Be Filed on Single Lawsuit in MDL: Judge (Posted: 2 days ago) The U.S. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITSuboxone Lawyers Report on Status of Lawsuits Over Tooth Decay, Dental Damage (03/11/2025)Medical Records of Suboxone Tooth Decay Must Be Produced Under MDL Court Order (02/20/2025)Lawyers in Suboxone Dental Lawsuits Fail To Reach Agreement on Bellwether Selection Process (02/06/2025)